Rhumbline Advisers raised its position in Acadia Healthcare Company Inc (NASDAQ:ACHC) by 2.5% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 152,573 shares of the company’s stock after acquiring an additional 3,698 shares during the period. Rhumbline Advisers owned approximately 0.17% of Acadia Healthcare worth $5,371,000 as of its most recent filing with the SEC.
A number of other institutional investors have also recently made changes to their positions in the business. BlackRock Inc. grew its stake in Acadia Healthcare by 2.1% in the second quarter. BlackRock Inc. now owns 10,336,713 shares of the company’s stock valued at $422,875,000 after acquiring an additional 210,999 shares during the period. JPMorgan Chase & Co. boosted its position in shares of Acadia Healthcare by 3.5% during the third quarter. JPMorgan Chase & Co. now owns 6,033,366 shares of the company’s stock valued at $212,375,000 after buying an additional 204,401 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Acadia Healthcare by 27.8% during the second quarter. Dimensional Fund Advisors LP now owns 5,153,977 shares of the company’s stock valued at $210,849,000 after buying an additional 1,122,452 shares during the last quarter. Stephens Investment Management Group LLC boosted its position in shares of Acadia Healthcare by 5.4% during the second quarter. Stephens Investment Management Group LLC now owns 1,100,971 shares of the company’s stock valued at $44,975,000 after buying an additional 56,255 shares during the last quarter. Finally, Glenmede Trust Co. NA boosted its position in shares of Acadia Healthcare by 4.1% during the second quarter. Glenmede Trust Co. NA now owns 1,028,476 shares of the company’s stock valued at $42,075,000 after buying an additional 40,147 shares during the last quarter.
Several research analysts recently issued reports on the company. Jefferies Financial Group reaffirmed a “buy” rating and set a $42.00 target price on shares of Acadia Healthcare in a research report on Monday, November 26th. ValuEngine cut Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Friday, November 16th. Cantor Fitzgerald reaffirmed a “hold” rating and set a $39.00 target price on shares of Acadia Healthcare in a research report on Friday, November 16th. UBS Group assumed coverage on Acadia Healthcare in a research report on Thursday, November 15th. They set a “neutral” rating and a $39.00 target price on the stock. Finally, Citigroup cut their target price on Acadia Healthcare from $46.00 to $43.00 and set a “buy” rating on the stock in a research report on Wednesday, November 14th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and four have given a buy rating to the company. Acadia Healthcare has an average rating of “Hold” and an average target price of $42.27.
Shares of Acadia Healthcare stock opened at $32.01 on Friday. The firm has a market cap of $2.92 billion, a P/E ratio of 13.91, a price-to-earnings-growth ratio of 1.44 and a beta of 0.16. Acadia Healthcare Company Inc has a 12 month low of $28.02 and a 12 month high of $45.35. The company has a debt-to-equity ratio of 1.19, a quick ratio of 1.26 and a current ratio of 1.26.
Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Monday, November 5th. The company reported $0.55 EPS for the quarter, missing the Zacks’ consensus estimate of $0.64 by ($0.09). The business had revenue of $760.90 million for the quarter, compared to the consensus estimate of $760.46 million. Acadia Healthcare had a return on equity of 7.71% and a net margin of 7.43%. The business’s revenue was up 6.2% compared to the same quarter last year. During the same quarter last year, the business posted $0.58 earnings per share. Research analysts anticipate that Acadia Healthcare Company Inc will post 2.29 EPS for the current year.
COPYRIGHT VIOLATION WARNING: “Rhumbline Advisers Increases Holdings in Acadia Healthcare Company Inc (ACHC)” was first reported by WKRB News and is owned by of WKRB News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this piece can be read at https://www.wkrb13.com/2018/12/07/rhumbline-advisers-increases-holdings-in-acadia-healthcare-company-inc-achc.html.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.
See Also: Trading Strategy Methods and Types
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company Inc (NASDAQ:ACHC).
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.